The iShares Genomics Immunology and Healthcare ETF (IDNA) is managed by BlackRock Fund Advisors (BFA), a leading investment management firm. The ETF seeks to track the NYSE FactSet Global Genomics and Immuno Biopharma Index, which comprises equity securities issued by companies in the biopharmaceutical and healthcare industries with a focus on genomics, immunology, and bioengineering. BFA uses a passive indexing approach to manage the fund, aiming to provide investors exposure to the growth and innovation in these fields while keeping costs and turnover low.
While the IDNA ETF, which tracks the NYSE® FactSet® Global Genomics and Immuno Biopharma Index, primarily focuses on capturing the potential growth and innovation in genomics and immunology sectors, it also offers a dividend distribution reflecting the underlying companies' dividend policies. The dividend distributions for IDNA are subject to the performance and dividend practices of the biopharmaceutical and healthcare equipment and services industries included in the ETF. Investors can expect these distributions to occur periodically, providing a potential source of income alongside exposure to the evolving fields of genomics, immunology, and bioengineering.
The iShares Genomics Immunology and Healthcare ETF (IDNA) is designed to closely follow the performance of the NYSE FactSet Global Genomics and Immuno Biopharma Index. Comprising companies engaged in biopharmaceuticals, healthcare equipment, and healthcare services, this ETF captures the growth and innovation potential within the genomics, immunology, and bioengineering sectors. With a representative sampling indexing strategy, IDNA offers investors exposure to companies driving advancements in medical sciences and technology.
Understanding the correlation dynamics of the iShares Genomics Immunology and Healthcare ETF (IDNA) is essential for investors looking to grasp its behavior within the broader healthcare and biopharmaceutical sectors. Given that IDNA tracks the NYSE® FactSet® Global Genomics and Immuno Biopharma Index, its correlation with companies in these industries becomes a focal point of analysis. Investors can benefit from studying IDNA's correlation with other healthcare and technology assets, utilizing tools like the ETF Insider web app to delve into intricate correlations, visualize overlaps, and make informed investment decisions based on comprehensive data.IDNA Sector
The iShares Genomics Immunology and Healthcare ETF (IDNA) primarily focuses on companies in the biopharmaceutical and healthcare equipment and services industries, particularly those involved in genomics, immunology, and bioengineering. This sector concentration allows investors to access companies positioned for long-term growth and innovation in these cutting-edge fields. By investing in a diversified range of companies within this sector, IDNA offers exposure to the advancements and developments shaping the future of healthcare and medicine.IDNA Exposure
The iShares Genomics Immunology and Healthcare ETF (IDNA) offers exposure to the rapidly evolving genomics, immunology, and healthcare sectors. By tracking the NYSE FactSet Global Genomics and Immuno Biopharma Index, IDNA allows investors to tap into companies that stand to benefit from advancements in these innovative industries. For comprehensive insights into IDNA's exposure and correlations with other ETFs, the ETF Insider web app provides an indispensable tool that simplifies data visualization and in-depth analysis, helping investors make informed decisions based on overlap and correlations within the market.
ETF Insider is a data-driven portfolio analytics and optimization platform that introduces a more efficient and practical way to visualize, analyze and optimize portfolios.
Rather than focusing on the surface-level attributes of ETFs and Mutual Funds, ETF Insider goes deeper by examining the underlying holdings of exchange traded products.
By organizing and structuring that data, investors can easily navigate within their overlapping layers.
This innovative perspective combined with modern data visualization and modeling tools, provides an entirely new approach to portfolio optimization that can quickly expose both portfolio inefficiencies and opportunities.
4 min read"Discover the details of the IDNA ETF with 'What is the IDNA ETF?' article. This informative piece dissects the fund's investment strategy, the make-up of its underlying assets, and its historical performance. Ideal for investors seeking to diversify their portfolio or anyone interested in financial markets, the article provides valuable insights into this specific ETF."
4 min readCompare the NUGT and PHYG ETFs with our thorough analysis. Dive into the performance metrics, underlying assets, and investment strategies.
4 min readEWZ, which stands for iShares MSCI Brazil ETF, is an exchange-traded fund that seeks to track the performance of the MSCI Brazil 25/50 Index. As an ETF, EWZ typically pays dividends to its shareholders on a quarterly basis. The specific dates for dividend payments may vary from year to year, so it is recommended to consult the official sources or the fund's prospectus for the most up-to-date information regarding dividend distribution.
ETF Insider is a novel portfolio optimization tool that uses the power of data visualization to gain insight into portfolio compositions, concentration risks, portfolio efficiency and more. Complex financial data can be transformed into visually appealing and easily digestible graphs and charts, allowing investors to quickly identify trends and make well-informed investment decisions. Not only does this save time, but it also increases the accuracy and effectiveness of portfolio management.
